Characteristic | N | Percent |
---|---|---|
Months since diagnosis (M, SD) | 13.9, 14.1 | Â |
Months on treatment (M, SD) | 5.9, 7.7 | Â |
Ostomy Appliance (n = 67) | 15 | 23.4 |
Adjuvant Therapy | 25 | 37.3 |
   Colon Stage II | 3 | 4.5 |
   Colon Stage III | 20 | 29.9 |
   Rectal Stage III | 2 | 2.9 |
   Initial diagnosis | 21 | 31.3 |
   Recurrence | 4 | 6.0 |
   Capecitabine | 12 | 17.9 |
   Folfiri | 1 | 1.5 |
   Folfox | 9 | 13.4 |
   Fufa | 3 | 4.5 |
Metastatic Therapy | 42 | 62.7 |
   Colon Stage IV | 39 | 58.2 |
   Rectal Stage IV | 3 | 4.5 |
   Initial diagnosis | 26 | 38.8 |
   Recurrence | 16 | 23.9 |
   Capecitabine | 16 | 23.9 |
   Folfiri | 13 | 19.4 |
   Folfox | 10 | 14.9 |
   Fufa | 2 | 2.9 |
   Tomudex | 1 | 1.5 |